Lopinavir: all 41 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 3
- Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaTerminatedNCT01095094Phase 2Results posted
- Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)TerminatedNCT01068873Phase 4Results posted
- Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIVCompletedNCT00949234Phase 2Results posted
- Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)CompletedNCT00928187Phase 3Results posted
- Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV DiseaseTerminatedNCT00775606Phase 4Results posted
- Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive SubjectsCompletedNCT00654147Phase 2Results posted
- Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected SubjectsCompletedNCT00358917Phase 3Results posted
- Kaletra Sex/Gender Pharmacokinetics (PK) StudyCompletedNCT00148759Phase 4Results posted
- Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIVCompletedNCT00035932Phase 3Results posted
- A Study of Combination Therapies to Treat COVID-19 InfectionWithdrawnNCT04459702Phase 2
- Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"Status unknownNCT04403100Phase 3
- OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor OutcomeWithdrawnNCT04365582Phase 3
- Evaluation of Low-dose Darunavir in a Switch StudyCompletedNCT02671383Phase 3
- Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialCompletedNCT02431975Phase 4
- Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With RifampinTerminatedNCT01700790Phase 4
- The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
- Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin LymphomaWithdrawnNCT01165645Not applicable
- Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis TherapyCompletedNCT01138202Phase 2
- Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in AfricaCompletedNCT01088516Phase 4
- Pilot Assessment of Lopinavir/Ritonavir and MaravirocTerminatedNCT00981318Phase 4
- Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected PatientsCompletedNCT00978237Phase 4
- CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesCompletedNCT00966160Phase 3
- Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.CompletedNCT00833378Phase 1
- An Evaluation of the Pharmacological Interaction of Lopinavir/r and RifampinCompletedNCT00771498Phase 4
- TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.CompletedNCT00767117Phase 1
- Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid MetabolismStatus unknownNCT00759070Phase 4
- Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected PatientsCompletedNCT00752037Phase 4
- Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based RegimensCompletedNCT00627055Phase 4
- Lopinavir/Ritonavir Monotherapy in ChildrenCompletedNCT00626301Phase 4
- A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory SyndromeStatus unknownNCT00578825Not applicable
- Raltegravir Kaletra PharmacokineticsCompletedNCT00564772Phase 4
- HIV Antiretroviral Drugs and MetabolismStatus unknownNCT00525239Not applicable
- The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected PatientsCompletedNCT00400738Phase 2
- Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.TerminatedNCT00386659Phase 4
- Drug Interaction Study Between Antimalarial and Anti-HIV MedicationsCompletedNCT00266058Phase 1
- Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsTerminatedNCT00144833Phase 3
- NRTI-Sparing Pilot StudyCompletedNCT00143689Phase 4
- Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin MetabolismCompletedNCT00135434Phase 1
- A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART RegimenCompletedNCT00135395Phase 3
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsCompletedNCT00056641Phase 2